Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 8;117(49):30898-30899.
doi: 10.1073/pnas.2017204117. Epub 2020 Nov 17.

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

Xiaoling Xu  1 , Mingfeng Han  2 , Tiantian Li  3 , Wei Sun  2 , Dongsheng Wang  3 , Binqing Fu  4   5 , Yonggang Zhou  4   5 , Xiaohu Zheng  4   5 , Yun Yang  6 , Xiuyong Li  7 , Xiaohua Zhang  2 , Aijun Pan  6 , Haiming Wei  8   5
Affiliations
Comment

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

Xiaoling Xu et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Comment on

References

    1. Wang Y., Mao Q., Zhou X., Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions? Proc. Natl. Acad. Sci. U.S.A. 117, 30896–30897 (2020). - PMC - PubMed
    1. Eimer J., et al. , Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: A retrospective cohort study. J. Intern. Med. (2020). - PMC - PubMed
    1. Price C. C., et al. , Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: Survival and clinical outcomes. Chest, 10.1016/j.chest.2020.06.006 (2020). - DOI - PMC - PubMed
    1. Toniati P., et al. , Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun. Rev. 19, 102568 (2020). - PMC - PubMed
    1. Klopfenstein T. et al. .; HNF Hospital Tocilizumab Multidisciplinary Team , Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Med. Mal. Infect. 50, 397–400 (2020). - PMC - PubMed

Substances